Latest Manufacturing News

Advanced Innergy Holdings has formalised its $0.40 per share offer to acquire Matrix Composites via a scheme of arrangement, aiming to expand its subsea manufacturing footprint across the Asia-Pacific region.

Matrix Composites & Engineering has agreed to a full acquisition by Advanced Innergy Holdings at $0.40 per share, delivering shareholders a premium of up to 68% over recent trading prices. The deal, backed unanimously by Matrix’s board, awaits shareholder and court approval with completion targeted for July 2026.

Hazer Group has completed a key Process Design Package with KBR, unlocking large-scale commercial potential for its methane pyrolysis technology. The company also signed a non-binding graphite offtake LOI with Green Steel WA and qualified its graphite for concrete and asphalt applications, all while maintaining a solid cash position and reducing cash burn.

EcoGraf has signed a non-binding MOU with Mitsubishi Chemical Corporation to explore supplying up to 10,000 tonnes per annum of spherical graphite and natural flake graphite for battery anode materials, advancing its vertically integrated strategy.

National Australia Bank is adjusting its credit provisioning and capital policies in response to market volatility from the Middle East conflict, with significant impacts on its 1H26 earnings and balance sheet.

Channel Infrastructure has locked in a government contract for 93 million litres of additional diesel storage at Marsden Point, adding about $8 million revenue in 2026 and reinforcing its role in New Zealand’s fuel security.

Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Life360 has reported its first full year of profitability alongside a 32% revenue surge to $489.5 million in 2025, driven by user growth, new Pet GPS subscriptions, and a strategic advertising platform acquisition.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.

Tivan Limited has confirmed its Speewah Fluorite Project can produce premium acidgrade fluorspar suitable for hydrofluoric acid, backed by positive technical assessments from Asian end-users. The company is advancing pilot production and finalising offtake agreements with Sumitomo Corporation and JOGMEC.

Carbonxt Group has secured $750,000 through convertible notes from major shareholder Phelbe Pty Ltd, targeting expansion of its Minnesota pellet manufacturing and increasing its New Carbon Processing stake to 48.1%.